This invention relates to the dialysis of blood in general, and more particularly to methods and apparatus for use in the same.
A healthy kidney removes toxic wastes and excess water from the blood. In End Stage Renal Disease (“ESRD”), or chronic kidney failure, the kidneys progressively stop performing these essential functions over a long period of time. When the kidneys fail, a patient dies within a short period of time unless that patient receives dialysis treatment for the rest of that patient's life or undergoes transplantation of a healthy, normal kidney. Since relatively few kidneys are currently available for transplantation, the overwhelming majority of patients with ESRD receive dialysis treatment.
Hemodialysis therapy is an extracorporeal (i.e., outside the body) process which removes toxins and water from a patient's blood. A hemodialysis machine pumps blood from the patient, through a dialyzer, and then back into the patient. The dialyzer removes the toxins and water from the blood by a membrane diffusion process. Typically, a patient with chronic kidney disease requires hemodialysis treatments three times per week, for 3-6 hours per session.
Thus, hemodialysis treatments require repetitive access to the vascular system of the patient.
One common method for repetitively accessing the vascular system of a patient for hemodialysis involves the use of a percutaneous catheter. The percutaneous catheter is inserted into a major vein, such as a femoral, subclavian or jugular vein. For long term maintenance dialysis, a jugular vein is generally the preferred insertion site. The catheter is percutaneous, with one end external to the body and the other end dwelling in either the superior vena cava or the right atrium of the heart. The external portion of the catheter has connectors permitting attachment of blood lines leading to and from the hemodialysis machine.
When hemodialysis is to be performed on a patient, the catheter's extracorporeal connector element 25 is appropriately connected to a dialysis machine (not shown), i.e., suction line 55 is connected to the suction port of the dialysis machine, and return line 65 is connected to the return port of the dialysis machine. The dialysis machine is then activated (i.e., the dialysis machine's blood pump is turned on and the flow rate set), whereupon the dialysis machine will withdraw relatively “dirty” blood from the patient through suction line 55 and return relatively “clean” blood to the patient through return line 65.
In order to minimize clotting within the hemodialysis catheter between dialysis sessions, the lumens of the hemodialysis catheter are typically filled with a diluted heparin solution (i.e., a “lock solution”) between the dialysis sessions. More particularly, after a dialysis session has been completed, a diluted heparin solution (i.e., the “lock solution”) is loaded into the lumens of the hemodialysis catheter and clamps set at the proximal end of the hemodialysis catheter (i.e., at the catheter's extracorporeal connector element 25). These clamps prevent the lock solution from draining out of the distal end of the catheter into systemic circulation. At the start of a hemodialysis session, the clamps are released and the lock solution is withdrawn from the hemodialysis catheter, whereupon the hemodialysis catheter is ready for use in a dialysis procedure.
It will be appreciated that the efficiency of a hemodialysis procedure will be reduced if there is recirculation of the dialyzed blood flow, i.e., if the cleansed blood returning to the body through the return line 65 is immediately drawn back into the suction line 55. To avoid this problem, hemodialysis catheters have traditionally staggered the openings 50, 60 of the lines 55, 65, respectively, in the manner shown in
One consequence of forming the hemodialysis catheter with the aforementioned “staggered tip” configuration (i.e., so that mouth 60 of return line 65 is disposed distal to mouth 50 of suction line 55) is that each lumen of the dual-lumen hemodialysis catheter is effectively dedicated to a particular function, i.e., line 65 is limited to use as a return line and line 55 is limited to use as a suction line. This point becomes clear if one considers the effect of reversing the use of each line, i.e., of using line 65 as a suction line and of using line 55 as a return line—in this reversed situation, the undesirable recirculation of the cleansed blood would tend to increase significantly, since the cleansed blood emerging from the mouth of the return line would be released just upstream of the mouth of the suction line, so that the cleansed blood would tend to be drawn back into the mouth of the suction line immediately after being returned to the body. As a result, there would be a significant reduction in the efficiency of a hemodialysis procedure (e.g., 15-30%, depending on the catheter tip design), and hence dialysis sessions would need to increase significantly in duration and/or frequency. Furthermore, if such a line reversal were to occur inadvertently and escape the attention of the attending medical personnel, the reduced hemodialysis efficiency might cause a patient to unknowingly receive inadequate dialysis during a treatment session, which could have serious health consequences for the patient.
The requirement that each line be dedicated to a particular function (i.e., suction or return, depending on whether its mouth is disposed proximal or distal to the mouth of its counterpart line) can be problematic in certain situations.
By way of example but not limitation, if a blood clot were to form in the suction line, it could be desirable to reverse flow through this line to see if the blood clot could be cleared from the catheter by forcing the blood clot out the distal end of the catheter. However, this approach requires the aforementioned line reversal, with the suction line being used as the return line and the return line being used as the suction line. As noted above, such line reversal is problematic where the hemodialysis catheter utilizes the aforementioned “staggered tip” construction.
By way of further example but not limitation, where the disposition of the hemodialysis catheter within the vascular system of the patient is such that suction from the suction line causes the hemodialysis catheter to repeatedly adhere to a vascular wall, it could be desirable to reverse flow through this line to avoid such recurrent adhesion. However, as noted above, such line reversal is problematic where the hemodialysis catheter utilizes the aforementioned “staggered tip” construction, since the mouth of the suction line should be disposed upstream of the mouth of the return line in order to minimize the recirculation of dialyzed blood.
The requirement that each line be dedicated to a particular function (i.e., suction or return, depending on whether its mouth is disposed proximal or distal to the mouth of its counterpart line) is eliminated if the two lines of the dialysis catheter co-terminate, i.e., if the mouths of the two lines are disposed in a side-by-side configuration, such as that shown in
Prior art hemodialysis catheters also tend to suffer from various additional deficiencies. By way of example but not limitation, even with the use of catheter lock solutions between dialysis sessions, blood clots may form in the mouths of one or both lumens of the hemodialysis catheter, and at locations between the mouths of the two lumens. This is particularly true during the time between dialysis sessions, when the hemodialysis catheter is not in active use. This is because the distal end of the hemodialysis catheter is disposed in a turbulent blood environment, and some of the catheter lock solution inevitably leaks out of the distal end of the hemodialysis catheter and is replaced by blood, which can then clot at the distal end of the hemodialysis catheter. These blood clots can be difficult and/or time-consuming to remove, thereby slowing down dialysis set-up and/or reducing dialysis throughput.
In this respect it should be appreciated that blood clot removal can be particularly difficult where side windows are formed adjacent to the distal ends of the lumens of the hemodialysis catheter, since portions of the blood clots may extend through the windows and thereby mechanically “lock” the blood clots to the hemodialysis catheter.
Therefore, it would be desirable to provide a new hemodialysis catheter which is configured to minimize the aforementioned undesirable recirculation of dialyzed blood, yet which allows its lumens to be interchangeably used for suction or return functions. It would also be desirable to provide a new hemodialysis catheter which minimizes the possibility of the catheter inadvertently adhering to vascular walls, and which simplifies removing any clots which might form adjacent to the distal end of the catheter. And it would be desirable to provide a new hemodialysis catheter which is easy to manufacture and inexpensive to produce.
The present invention provides a novel method and apparatus for the dialysis of blood. Among other things, the present invention comprises the provision and use of a novel hemodialysis catheter which is configured to minimize the aforementioned undesirable recirculation of dialyzed blood, yet which allows its lumens to be interchangeably used for suction or return functions. The novel hemodialysis catheter is also designed to minimize the possibility of the catheter inadvertently adhering to vascular walls, and to simplify removal of any clots which might form adjacent to the distal end of the catheter. And the novel hemodialysis catheter is easy to manufacture and inexpensive to produce.
In one form of the invention, there is provided apparatus for use in dialyzing a patient, the apparatus comprising:
a hemodialysis catheter comprising:
In one preferred form of the invention, where the dialysis flow rate is between about 350 mL/minute and 500 mL/minute, and where the suction (vacuum) prepump pressure is not more negative than about −250 mm/Hg and the return pressure does not exceed about 250 mm/Hg, and where the suction line and the return line both have D-shaped cross-sections with a longer dimension of about 3.5 mm and a shorter dimension of about 1.5 mm, the first and second longitudinal slots preferably have a slot width of about 0.065-0.100 inches, and a slot length of greater than 5 mm, with a slot length of 10 mm being preferred. In this respect it should be appreciated that an appropriate slot width is important to allow sufficient flow rates at acceptable pressure gradients, and an appropriate slot length is important to minimize recirculation.
In another form of the invention, there is provided apparatus for use in dialyzing a patient, the apparatus comprising:
a hemodialysis catheter system comprising:
In another form of the invention, there is provided a method for dialyzing the blood of a patient, the method comprising:
providing apparatus for use in dialyzing a patient, the apparatus comprising:
connecting the first lumen to the venous port of a dialysis machine, and connecting the second lumen to the arterial port of the dialysis machine; and
withdrawing undialyzed blood from the body of a patient through the first lumen, and returning dialyzed blood to the body of a patient through the second lumen.
In another form of the invention, there is provided apparatus for use in withdrawing fluids from a patient and instilling fluids into a patient, the apparatus comprising:
a catheter comprising:
In another form of the invention, there is provided apparatus for use in withdrawing fluids from a patient and instilling fluids into a patient, the apparatus comprising:
a catheter system comprising:
In another form of the invention, there is provided a method for withdrawing fluids from a patient and instilling fluids into a patient, the method comprising:
providing apparatus for use in withdrawing fluids from a patient and instilling fluids into a patient, the apparatus comprising:
connecting the first lumen to a source of suction, and connecting the second lumen to a source of fluid; and
withdrawing fluid from the body of a patient through the first lumen, and instilling fluid into the body of a patient through the second lumen.
These and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts, and further wherein:
The present invention provides a novel method and apparatus for the dialysis of blood. Among other things, the present invention comprises the provision and use of a novel hemodialysis catheter which is configured to minimize the aforementioned undesirable recirculation of dialyzed blood, yet which allows its lumens to be interchangeably used for suction or return functions. The novel hemodialysis catheter of the present invention is also designed to minimize the possibility of the catheter inadvertently adhering to vascular walls, and to simplify removal of any clots which might form adjacent to the distal end of the catheter. And the novel hemodialysis catheter of the present invention is easy to manufacture and inexpensive to produce.
More particularly, and looking now at
Significantly, mouth 150 of first lumen 155 and mouth 160 of second lumen 165 are disposed in a side-by-side configuration, with the dual-lumen catheter element 115 terminating in a substantially flat distal end surface 175. Flat distal end surface 175 of dual-lumen catheter element 115 preferably extends substantially perpendicular to the longitudinal axes of first lumen 155 and second lumen 165. By disposing mouths 150 and 160 in the aforementioned side-by-side configuration, lumens 155 and 165 may be interchangeably used for suction or return applications, as will hereinafter be discussed.
Also significantly, a pair of longitudinal slots 180, 185 are formed in the side walls of distal end 135 of dual-lumen catheter element 115, with longitudinal slot 180 extending along and communicating with the interior of first lumen 155, and with longitudinal slot 185 extending along and communicating with the interior of second lumen 165. Preferably longitudinal slots 180, 185 extend at a right angle to the plane of the septum 190 which separates first lumen 155 from second lumen 165. By providing first lumen 155 and second lumen 165 with the aforementioned longitudinal slots 180, 185, respectively, the aforementioned undesirable recirculation of dialyzed blood is minimized, even though the mouths 150, 160 of the lumens 155, 165, respectively, are disposed in a side-by side configuration, as will hereinafter be discussed.
In one preferred form of the present invention, the distal end 135 of catheter element 115 has a substantially round outer surface (i.e., the distal end 135 of catheter element 115 has a substantially round cross-section), and first lumen 155 and second lumen 165 are each formed with a substantially D-shaped cross-section (
When hemodialysis is to be performed on a patient, extracorporeal connector element 125 of hemodialysis catheter 105 is appropriately connected to a dialysis machine (not shown), e.g., first line 155 is connected to the suction port of the dialysis machine, and second line 165 is connected to the return port of the dialysis machine. In this case, first line 155 serves as the suction line and second line 165 serves as the return line. Alternatively, first line 155 is connected to the return port of the dialysis machine, and second line 165 is connected to the suction port of the dialysis machine. In this case, first line 155 serves as the return line and second line 165 serves as the suction line. It is a significant aspect of the present invention that the lumens of the hemodialysis catheter 105 are not dedicated to a particular function, i.e., either lumen may be used for suction function and either lumen may be used for return function.
For the purposes of the description which hereinafter follows, it will be assumed that first line 155 is connected to the suction port of the dialysis machine, and second line 165 is connected to the return port of the dialysis machine. In this case, first line 155 serves as the suction line to withdraw undialyzed blood from the patient and second line 165 serves as the return line to return dialyzed blood to the patient.
The dialysis machine is then activated (i.e., the dialysis machine's blood pump is turned on and the flow rate set), whereupon the dialysis machine will withdraw relatively “dirty” blood from the patient through suction line 155 and return relatively “clean” blood to the patient through return line 165.
Significantly, with the novel hemodialysis catheter of the present invention, there is minimal undesirable recirculation of the undialyzed blood, even though mouth 150 of first lumen 155 (i.e., the mouth of the suction line) is disposed immediately adjacent to mouth 160 of second lumen 165 (i.e., the mouth of the return line) in a side-by-side relation. This is due to the novel provision of the aforementioned longitudinal slots 180, 185. More particularly, and looking now at
More particularly, it has been discovered that, by controlling certain parameters of the hemodialysis system, the recirculation rate of the dual-lumen, flat-end hemodialysis catheter 105 can be minimized. These parameters include, but are not limited to, (i) the size of lumens 155, 165; (ii) the length and width of longitudinal slots 180, 185; (iii) the thickness of the side wall of hemodialysis catheter 105 at longitudinal slots 180, 185; and (iv) the rate of flow through hemodialysis catheter 105. Another factor affecting the rate of recirculation of hemodialysis catheter 105 is the rate of flow of the ambient blood surrounding hemodialysis catheter 105.
In general, it is preferred that longitudinal slots 180, 185 be sized so that greater than 85% of the flow out of the return line exits the distal mouth of that line, and so that greater than 85% of the flow into the suction line enters the proximal ⅓rd of its associated longitudinal slot, and so that the hemodialysis catheter has a recirculation rate of less than 1%.
In general, it is also preferred that longitudinal slots 180, 185 have a length of between approximately 8 mm and 30 mm, since this length is long enough to adequately separate the inflow and outflow streams and thereby minimize recirculation, but short enough that the entire length of the longitudinal slots 180, 185 can fit within the right atrium of the heart. In addition, it has been found that by providing longitudinal slots 180, 185 with a length of between approximately 8 mm and 30 mm, the hemodialysis catheter will function with the desired minimal recirculation rate while minimizing loss of the catheter lock solution through longitudinal slots 180, 185.
In general, it is preferred that the lumens 155, 165 have a D-shaped configuration, and that the width of the longitudinal slots 180, 185 be between approximately 30% and 60% of the longer dimension 195 of the D-shaped lumen.
By way of example but not limitation, where the hemodialysis catheter 105 has a diameter of 15.5 French (i.e., 0.202 inch), where its lumens 155, 165 have a substantially D-shaped cross-section characterized by a longer dimension 195 of 3.5 mm (i.e., 0.14 inch) and a shorter dimension 200 of 1.5 mm (i.e., 0.060 inch), and where the flow rate of each lumen is to be set at 350-450 mL per minute, it is desirable that longitudinal slots 180, 185 have a length of 10 mm (i.e., 0.394 inch) and a width of 1.5 mm (i.e., 0.059 inch), whereby to produce a recirculation rate of less than 1%.
Among other things, it should be appreciated that an appropriate slot width is important to allow sufficient flow rates at acceptable pressure gradients, and an appropriate slot length is important to minimize recirculation. In this respect it will be appreciated that a wider slot and lower pressure gradients help minimize hemolysis.
In addition to the foregoing, it should also be appreciated that, even though the distal end of novel hemodialysis catheter 105 terminates in a flat distal end surface 175, with mouths 150 and 160 arranged in a side-by-side configuration, the construction of hemodialysis catheter 105 minimizes the possibility of the catheter inadvertently adhering to vascular walls. This is also due to the provision of the aforementioned longitudinal slots 180, 185. More particularly, with the hemodialysis catheter of the present invention, if the flat distal end surface 175 of the dialysis catheter should encounter a vascular wall, the longitudinal slot associated with the suction line will admit blood into the suction lumen, thereby keeping the distal end of the hemodialysis catheter from significantly adhering to the vascular wall. This happens because “suction forces” to adhere the catheter to the vascular wall cannot be maintained, since there are two openings (i.e., the slot opening and the distal end opening) and these two openings are spaced from one another and located 90° apart.
Also, if a blood clot should form at the distal end of hemodialysis catheter 105, e.g., during periods between dialysis sessions, the construction of the hemodialysis catheter makes it a simple matter to clear the blood clot from the distal end of the catheter. More particularly, inasmuch as the longitudinal slots 180, 185 extend all the way to the distal end of the hemodialysis catheter, any blood clots forming on the distal end of the hemodialysis catheter can be easily removed from the hemodialysis catheter by simply “blowing” the blood clots out the distal end of the hemodialysis catheter—there is no mechanical adhesion of the blood clot to the hemodialysis catheter, as there might be, for example, if the longitudinal slots 180, 185 were replaced by windows, in which case a portion of the blood clot might protrude through the window and mechanically “lock” the blood clot to the hemodialysis catheter.
And the hemodialysis catheter is exceedingly simple in design, making it easy to manufacture and inexpensive to produce.
Thus it will be seen that the present invention provides a novel hemodialysis catheter which is configured to minimize undesirable recirculation of dialyzed blood, yet which allows its lumens to be interchangeably used for suction or return functions. And the present invention provides a novel hemodialysis catheter that minimizes the possibility of the catheter inadvertently adhering to vascular walls, and which simplifies the removal of any clots which might form on the distal end of the catheter. And the present invention provides a novel hemodialysis catheter which is easy to manufacture and inexpensive to produce.
If desired, a novel open/close valve may be incorporated into each of the blood lines of novel hemodialysis catheter 105 in order to facilitate flow control through the blood line.
More particularly, in prior art hemodialysis catheters, clamps are applied to the suction and return lines at the proximal end of the hemodialysis catheter in order to close off flow when desired, e.g., when the hemodialysis catheter is not connected to a dialysis machine, etc. However, these clamps are essentially hose clamps which compress the suction and return lines of the hemodialysis catheter. This can cause damage to the suction and return lines, particularly over time. Furthermore, these clamps are bulky and present edges, which makes them uncomfortable for the patient. To this end, the present invention provides a novel open/closed valve which may be incorporated into each of the blood lines of the novel hemodialysis catheter in order to facilitate flow control through the blood line.
In one preferred form of the invention, and looking now at
In practice, it is generally desirable to deploy a hemodialysis catheter so that the hemodialysis catheter enters a jugular vein of the patient and, furthermore, so that the hemodialysis catheter extends a distance under the skin before entering the jugular vein of the patient. This approach allows the access end of the hemodialysis catheter to exit the skin of the patient at the chest of the patient even as the working end of the hemodialysis catheter enters a jugular vein for direct passage down to the superior vena cava or the right atrium of the heart.
The procedure for deploying a hemodialysis catheter in this manner will now be described, with reference being made to
1. locate the jugular vein 40 which is to be accessed;
2. make a first incision 225 into the skin near the jugular vein;
3. use the Seldinger technique to access the jugular vein, i.e., place a guidewire (not shown) into the jugular vein, and then place an introducer sheath (not shown) over the guidewire and into the jugular vein;
4. make a second incision 230 into the skin on the chest;
5. advance the hemodialysis catheter, distal end first, through the second incision 230 on the chest, pass the hemodialysis catheter under the skin and then out first incision 225 below the clavicle; and
6. insert the distal end of the hemodialysis catheter into the jugular vein by means of the guidewire and the introducer sheath.
As noted above, in the foregoing Step 5, when the hemodialysis catheter is advanced from the second incision 230 on the chest up to the first incision 225, the hemodialysis catheter is passed distal end first, so that the distal end of the hemodialysis catheter is ready to be passed into the jugular vein of the patient.
In accordance with the present invention, and looking now at
More particularly, tunneling tool 240 generally comprises a shaft 245 terminating at its distal end in a blunt end 250 and terminating at its proximal end in a frustoconical section 255. Frustoconical section 235 supports a pair of substantially parallel fingers 260. Fingers 260 are relatively stiff, but are capable of flexing toward and away from one another. Fingers 260 preferably each include a plurality of projections 265, with the projections 265 of one finger 260 extending toward the opposing finger 260. Fingers 260 have a length and a width such that they can be received in the aforementioned longitudinal slots 180, 185 formed in the distal end of the hemodialysis catheter 105, when the flat distal end surface 175 of the hemodialysis catheter 105 abuts frustoconical section 255. A tapered sleeve 270 is slidably mounted on shaft 230. Sleeve 270 may be slid proximally along shaft 245 and over fingers 260 so as to bend fingers 260 inwardly, in a camming action, whereby to cause the fingers 260 to grip septum 190 of hemodialysis catheter 105, and hence grip the distal end of the hemodialysis catheter, e.g., in the manner of a collet. When the hemodialysis catheter 105 is to be released from tunneling tool 240, tapered sleeve 270 is slid distally, away from the hemodialysis catheter, whereby to allow fingers 260 to relax and thereby release the distal end of the hemodialysis catheter.
If desired, and looking now at
In still another form of the invention, and looking now at
It should be appreciated that the aforementioned two lumen hemodialysis catheter 105, and/or the aforementioned several single-lumen hemodialysis catheters 275, and/or the aforementioned three or more lumen apheresis catheter 300 may be used in conjunction with an implantable port and/or other systems that exchange (remove and instill) bodily fluids. By way of example but not limitation,
It should be understood that many additional changes in the details, materials, steps and arrangements of parts, which have been herein described and illustrated in order to explain the nature of the present invention, may be made by those skilled in the art while still remaining within the principles and scope of the invention.
This patent application is a continuation application of co-pending U.S. application Ser. No. 15/848,738, filed Dec. 20, 2017, which is continuation of U.S. application Ser. No. 14/728,026 (now U.S. Pat. No. 10,004,842), which is a continuation of U.S. application Ser. No. 13/584,177 (now U.S. Pat. No. 9,044,573). This application is related to and claims the benefit of: (i) prior U.S. Provisional Patent Application Ser. No. 61/522,568, filed Aug. 11, 2011 by Adrian Ravenscroft et al. for APPARATUS AND METHOD FOR THE DIALYSIS OF BLOOD;(ii) prior U.S. Provisional Patent Application Ser. No. 61/638,079, filed Apr. 25, 2012 by Adrian Ravenscroft et al. for METHOD AND APPARATUS FOR THE DIALYSIS OF BLOOD;(iii) U.S. application Ser. No. 13/584,177 (now U.S. Pat. No. 9,044,573);(iv) U.S. application Ser. No. 14/728,026 (now U.S. Pat. No. 10,004,842); and;(v) U.S. application Ser. No. 15,848,738. The five (5) above-identified patent applications are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2972779 | Cowley | Feb 1961 | A |
3434691 | Hamilton | Mar 1969 | A |
3906932 | Tyres | Sep 1975 | A |
3965901 | Penny et al. | Jun 1976 | A |
4134402 | Mahurkar | Jan 1979 | A |
4403983 | Edelman et al. | Sep 1983 | A |
4423740 | Castle et al. | Jan 1984 | A |
4639246 | Dudley | Jan 1987 | A |
4692141 | Mahurkar | Sep 1987 | A |
4842592 | Caggiani et al. | Jun 1989 | A |
4895561 | Mahurkar | Jan 1990 | A |
5009636 | Wortley et al. | Apr 1991 | A |
5112301 | Fenton et al. | May 1992 | A |
5147332 | Moorehead | Sep 1992 | A |
5178611 | Rosenberg | Jan 1993 | A |
5190520 | Fenton et al. | Mar 1993 | A |
5195962 | Martin et al. | Mar 1993 | A |
5203769 | Clement et al. | Apr 1993 | A |
5209723 | Twardowski et al. | May 1993 | A |
5254106 | Feaster | Oct 1993 | A |
5324274 | Martin | Jun 1994 | A |
5374245 | Mahurkar | Dec 1994 | A |
5395316 | Martin | Mar 1995 | A |
5399172 | Martin et al. | Mar 1995 | A |
5405320 | Twardowski et al. | Apr 1995 | A |
5472417 | Martin et al. | Dec 1995 | A |
5472432 | Martin | Dec 1995 | A |
5486159 | Mahurkar | Jan 1996 | A |
5531673 | Helenowski | Jul 1996 | A |
5536261 | Stevens | Jul 1996 | A |
5569182 | Twardowski et al. | Oct 1996 | A |
5636875 | Wasser | Jun 1997 | A |
5685867 | Twardowski et al. | Nov 1997 | A |
5693030 | Lee et al. | Dec 1997 | A |
5797869 | Martin et al. | Aug 1998 | A |
5810792 | Fangrow et al. | Sep 1998 | A |
5820610 | Baudino | Oct 1998 | A |
5830196 | Hicks | Nov 1998 | A |
5961486 | Twardowski et al. | Oct 1999 | A |
5976114 | Jonkman et al. | Nov 1999 | A |
6096798 | Luthra et al. | Aug 2000 | A |
6102884 | Squitieri | Aug 2000 | A |
6206849 | Martin et al. | Mar 2001 | B1 |
6406687 | Luthra et al. | Jun 2002 | B1 |
6409700 | Siegel et al. | Jun 2002 | B1 |
6423053 | Lee | Jul 2002 | B1 |
6447488 | Estabrook et al. | Sep 2002 | B2 |
6461321 | Quinn | Oct 2002 | B1 |
6540714 | Quinn | Apr 2003 | B1 |
6551291 | De et al. | Apr 2003 | B1 |
6582409 | Squitieri | Jun 2003 | B1 |
6702776 | Quinn | Mar 2004 | B2 |
6712797 | Southern, Jr. | Mar 2004 | B1 |
6736884 | Virgilio | May 2004 | B2 |
6758836 | Zawacki | Jul 2004 | B2 |
6786884 | Decant et al. | Sep 2004 | B1 |
6969373 | Schwartz et al. | Nov 2005 | B2 |
7034061 | Luthra et al. | Apr 2006 | B1 |
7056286 | Ravenscroft et al. | Jun 2006 | B2 |
7090654 | Lotito et al. | Aug 2006 | B2 |
7141035 | Haggstrom | Nov 2006 | B2 |
7182746 | Haarala et al. | Feb 2007 | B2 |
D540467 | Mori | Apr 2007 | S |
D541936 | Patterson | May 2007 | S |
7211074 | Sansoucy | May 2007 | B2 |
7229429 | Martin et al. | Jun 2007 | B2 |
D550839 | Zawacki et al. | Sep 2007 | S |
7320674 | Ruddell et al. | Jan 2008 | B2 |
7322953 | Redinger | Jan 2008 | B2 |
7393339 | Zawacki et al. | Jul 2008 | B2 |
D581529 | Moehle et al. | Nov 2008 | S |
7485107 | Difiore et al. | Feb 2009 | B2 |
7569029 | Clark | Aug 2009 | B2 |
D603044 | Appling et al. | Oct 2009 | S |
7655000 | Walls et al. | Feb 2010 | B2 |
RE41448 | Squitieri | Jul 2010 | E |
7749185 | Wilson et al. | Jul 2010 | B2 |
7776005 | Haggstrom et al. | Aug 2010 | B2 |
D640788 | Appling | Jun 2011 | S |
8007488 | Ravenscroft | Aug 2011 | B2 |
8021321 | Zawacki | Sep 2011 | B2 |
8052659 | Ravenscroft et al. | Nov 2011 | B2 |
8066660 | Gregersen et al. | Nov 2011 | B2 |
8092415 | Moehle et al. | Jan 2012 | B2 |
8123892 | Morris et al. | Feb 2012 | B2 |
D657461 | Schembre et al. | Apr 2012 | S |
8152951 | Zawacki et al. | Apr 2012 | B2 |
8292841 | Gregersen | Oct 2012 | B2 |
8323227 | Hamatake et al. | Dec 2012 | B2 |
8328760 | Lareau | Dec 2012 | B2 |
8337451 | Lareau et al. | Dec 2012 | B2 |
8343104 | Martin et al. | Jan 2013 | B2 |
8403911 | Adams et al. | Mar 2013 | B2 |
8454565 | Braga et al. | Jun 2013 | B2 |
8496607 | Feng et al. | Jul 2013 | B2 |
8496629 | Mckinnon et al. | Jul 2013 | B2 |
8500939 | Nimkar et al. | Aug 2013 | B2 |
8517978 | Clark | Aug 2013 | B2 |
D690009 | Schembre et al. | Sep 2013 | S |
8540661 | Gregersen | Sep 2013 | B2 |
RE44639 | Squitieri | Dec 2013 | E |
8636682 | Deshpande | Jan 2014 | B2 |
8679091 | Morris et al. | Mar 2014 | B2 |
8696614 | Gregersen et al. | Apr 2014 | B2 |
8747343 | Macmeans et al. | Jun 2014 | B2 |
8808227 | Zawacki et al. | Aug 2014 | B2 |
8894601 | Moehle et al. | Nov 2014 | B2 |
8894607 | Barrett et al. | Nov 2014 | B2 |
8920404 | Difiore et al. | Dec 2014 | B2 |
9005154 | Matson et al. | Apr 2015 | B2 |
9044573 | Ravenscroft et al. | Jun 2015 | B2 |
9056183 | Deshpande | Jun 2015 | B2 |
D736916 | Appling et al. | Aug 2015 | S |
9138567 | Pruitt et al. | Sep 2015 | B2 |
9155862 | Bellisario et al. | Oct 2015 | B2 |
9168355 | Braga | Oct 2015 | B2 |
9174019 | Gregersen | Nov 2015 | B2 |
9192710 | Feng et al. | Nov 2015 | B2 |
D748252 | King et al. | Jan 2016 | S |
9233200 | Gregersen et al. | Jan 2016 | B2 |
9238122 | Malhi et al. | Jan 2016 | B2 |
9248253 | Melsheimer et al. | Feb 2016 | B2 |
9333321 | Clark | May 2016 | B2 |
9387304 | Zawacki et al. | Jul 2016 | B2 |
9399112 | Shevgoor et al. | Jul 2016 | B2 |
D767127 | De | Sep 2016 | S |
9463300 | Pruitt et al. | Oct 2016 | B2 |
9526861 | Bellisario et al. | Dec 2016 | B2 |
9579485 | Oborn et al. | Feb 2017 | B2 |
9610422 | Moehle et al. | Apr 2017 | B2 |
9642962 | Matson et al. | May 2017 | B2 |
9656041 | Hamatake et al. | May 2017 | B2 |
9687269 | Parent | Jun 2017 | B2 |
9713694 | Braga et al. | Jul 2017 | B2 |
10004842 | Ravenscroft et al. | Jun 2018 | B2 |
20030082080 | Zimmermann et al. | May 2003 | A1 |
20030144623 | Heath et al. | Jul 2003 | A1 |
20040006318 | Periakaruppan et al. | Jan 2004 | A1 |
20040006331 | Shchervinsky | Jan 2004 | A1 |
20040034324 | Seese et al. | Feb 2004 | A1 |
20040116844 | Takahashi et al. | Jun 2004 | A1 |
20040193102 | Haggstrom | Sep 2004 | A1 |
20040193119 | Canaud et al. | Sep 2004 | A1 |
20050027282 | Schweikert et al. | Feb 2005 | A1 |
20050033222 | Haggstrom et al. | Feb 2005 | A1 |
20050033264 | Redinger | Feb 2005 | A1 |
20050043682 | Kucklick et al. | Feb 2005 | A1 |
20050070842 | Lotito et al. | Mar 2005 | A1 |
20050182352 | Dimatteo et al. | Aug 2005 | A1 |
20050197633 | Schwartz et al. | Sep 2005 | A1 |
20050228364 | Braga | Oct 2005 | A1 |
20050267400 | Haarala et al. | Dec 2005 | A1 |
20060004316 | Difiore et al. | Jan 2006 | A1 |
20060004324 | Ruddell et al. | Jan 2006 | A1 |
20060004325 | Hamatake | Jan 2006 | A1 |
20060009783 | Rome et al. | Jan 2006 | A1 |
20060015086 | Rasmussen et al. | Jan 2006 | A1 |
20060064159 | Porter et al. | Mar 2006 | A1 |
20060095062 | Stephens | May 2006 | A1 |
20060100872 | Yokoi | May 2006 | A1 |
20060189922 | Amarasinghe et al. | Aug 2006 | A1 |
20070049787 | Nose et al. | Mar 2007 | A1 |
20070060888 | Goff et al. | Mar 2007 | A1 |
20070078437 | Borden et al. | Apr 2007 | A1 |
20070123811 | Squitieri | May 2007 | A1 |
20080082079 | Braga et al. | Apr 2008 | A1 |
20080082080 | Braga | Apr 2008 | A1 |
20090005762 | Nishtala et al. | Jan 2009 | A1 |
20090093748 | Patterson et al. | Apr 2009 | A1 |
20090112153 | Gregersen et al. | Apr 2009 | A1 |
20090118661 | Moehle et al. | May 2009 | A1 |
20090137944 | Haarala et al. | May 2009 | A1 |
20090187141 | Lareau et al. | Jul 2009 | A1 |
20090216174 | Nardeo | Aug 2009 | A1 |
20100063512 | Braga et al. | Mar 2010 | A1 |
20100324368 | Mathieu | Dec 2010 | A1 |
20100331823 | Blanchard | Dec 2010 | A1 |
20110015559 | Mcguckin et al. | Jan 2011 | A1 |
20110077577 | Sansoucy | Mar 2011 | A1 |
20110130745 | Shevgoor et al. | Jun 2011 | A1 |
20110137225 | Feng et al. | Jun 2011 | A1 |
20110144620 | Tal | Jun 2011 | A1 |
20110152841 | Nemoto | Jun 2011 | A1 |
20110172642 | Lareau | Jul 2011 | A1 |
20110196190 | Farnan et al. | Aug 2011 | A1 |
20110213291 | Quinn | Sep 2011 | A1 |
20110214656 | Saunders | Sep 2011 | A1 |
20130053763 | Makino et al. | Feb 2013 | A1 |
20130085438 | Macmeans et al. | Apr 2013 | A1 |
20130085477 | Deshpande | Apr 2013 | A1 |
20130253445 | Nimkar et al. | Sep 2013 | A1 |
20130289532 | Mckinnon et al. | Oct 2013 | A1 |
20140012209 | Sansoucy | Jan 2014 | A1 |
20140018772 | Ash | Jan 2014 | A1 |
20140316382 | Morris et al. | Oct 2014 | A1 |
20150306302 | Marsden et al. | Oct 2015 | A1 |
20160051745 | Gregersen | Feb 2016 | A1 |
20160114093 | Ravenscroft et al. | Apr 2016 | A1 |
20160121040 | Gregersen et al. | May 2016 | A1 |
20160128715 | Malhi et al. | May 2016 | A1 |
20160250441 | Clark | Sep 2016 | A1 |
20160325072 | Shevgoor et al. | Nov 2016 | A1 |
20170035987 | Ardehali | Feb 2017 | A1 |
20170100560 | Bellisario et al. | Apr 2017 | A1 |
20170165453 | Oborn et al. | Jun 2017 | A1 |
Number | Date | Country |
---|---|---|
2168611 | Mar 2010 | EP |
2010146614 | Dec 2010 | WO |
Entry |
---|
Kelli Rosenthal, “An Introduction to Apheresis”, Resource Nurse, 2000-2007, 3 pages. |
Rhodes et al., “Apheresis: An Overview of Procedures and Need for Vascular Access Devices”, Journal of the Association for Vascular Access, vol. 9, No. 4, Dec. 2004, pp. 218-220. |
Robbins et al., “Reverse Catheter Placement: A Modification of the Blom-Singer Tracheoesophageal Puncture Technique”, The Journal of Otolaryngology, Jun. 1993, pp. 204-205. |
Number | Date | Country | |
---|---|---|---|
20200384183 A1 | Dec 2020 | US |
Number | Date | Country | |
---|---|---|---|
61638079 | Apr 2012 | US | |
61522568 | Aug 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15848738 | Dec 2017 | US |
Child | 17000512 | US | |
Parent | 14728026 | Jun 2015 | US |
Child | 15848738 | US | |
Parent | 13584177 | Aug 2012 | US |
Child | 14728026 | US |